Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lupski Lab, |
RCV000203269 | SCV000256743 | pathogenic | Benign concentric annular macular dystrophy | 2014-09-25 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV002517362 | SCV003333832 | uncertain significance | Leber congenital amaurosis 7; Cone-rod dystrophy 2 | 2022-04-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 218922). This variant has not been reported in the literature in individuals affected with CRX-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr221Thrfs*9) in the CRX gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 79 amino acid(s) of the CRX protein. |